We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Get help to classify textiles and which headings and codes to use.
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
Guidance on the mammographic aspects (both clinical and technical) of breast screening QA and the quality control of radiographic procedures.
These publications explain breast screening and support the NHS Breast Screening Programme.
NHS Breast Screening Programme position statement on reporting of breast density
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Population screening programmes: NHS breast screening (BSP) programme. The pages tagged as BSP will appear here.
This paper aims to assess the effects of different treatments for the management of breast abscesses in breastfeeding women
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
This guidance explains what the Sloane Project is and how breast screening units (BSUs) can submit data.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
This page provides information for local area partnerships submitting expressions of interest (EOIs) to apply for funding to participate in the £10.9 million expansion of the Create Growth Programme.
This study examines whether increasing fluid intake has a beneficial effect on breast milk production and infant growth
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.